Gilead Sciences

American pharmaceutical company

Gilead Sciences    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.


You Might Like

Covid hit access to treatment for India’s 21 lakh HIV+ patients: Gilead survey

IndiaTimes - Published

Swadeshi Jagran Manch asks govt to revoke Remdesivir's patent

RSS affiliate Swadeshi Jagran Manch has asked the government to revoke the patent granted to Gilead Sciences for Remdesivir, a crucial medicine used in the treatment of Covid-19, so that it becomes..
IndiaTimes - Published

FDA warns against combination of malaria drug and Gilead's remdesivir

The U.S. Food and Drug Administration on Monday issued a warning to healthcare providers against administering malaria drug hydroxychloroquine or chloroquine in combination with Gilead Sciences'..
Reuters India - Published

India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivir

Indian drugmaker Zydus Cadila said on Friday it signed a non-exclusive licensing pact with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show..
Reuters India - Published

India's Zydus Cadila signs pact with Gilead to make remdesivir

Indian drugmaker Zydus Cadila said on Friday it signed a non-exclusive agreement with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in..
Reuters India - Published

Gilead's remdesivir prevents lung damage in COVID-19 study on monkeys

Gilead Sciences Inc's antiviral drug remdesivir prevented lung disease in macaque monkeys infected with the new coronavirus, according to a study published in the journal Nature on Tuesday.
Reuters India - Published

India approves Gilead's remdesivir to treat severe COVID-19 cases

India's government has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use for five doses in treating COVID-19 patients.
Reuters India - Published

Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions

Gilead Sciences Inc is developing easier-to-administer versions of its antiviral treatment remdesivir for COVID-19 that could be used outside of hospitals, including ones that can be inhaled, after..
Reuters India - Published

India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir

India's drug regulator has granted US pharma giant Gilead Sciences marketing authorisation for its anti-viral drug remdesivir for "restricted emergency use" on hospitalised Covid-19 patients in view of..
IndiaTimes - Published

South Korea seeks to import anti-viral remdesivir as new coronavirus cases emerge

South Korean health authorities said on Friday they would request imports of Gilead Sciences Inc's anti-viral drug remdesivir to treat COVID-19, as new outbreaks of the disease flare as social..
Reuters - Published

Britain to provide anti-viral drug remdesivir to some COVID-19 patients

Britain will provide the anti-viral drug remdesivir to certain COVID-19 patients that it is most likely to benefit as part of a collaboration with manufacturer Gilead Sciences, the health ministry said..
Reuters - Published

U.S. doctors call for remdesivir data to guide coronavirus treatment

U.S. doctors and others in the scientific community are calling for the release of data that convinced health regulators to authorize emergency use of Gilead Sciences Inc's antiviral drug remdesivir to..
Reuters India - Published

Remdesivir close to EU's initial authorisation as COVID-19 treatment

The head of the European Union's medicines agency Guido Rasi said on Monday an initial authorisation for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in..
Reuters India - Published

Part of Gilead's coronavirus drug donation allocated to Japan

Japan has begun treating severely ill COVID-19 patients with Gilead Sciences Inc's coronavirus drug remdesivir, days after granting emergency approval to the medication the company is supplying as part..
Reuters India - Published

Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir

Two health advocacy groups have written to the Indian government asking it to rescind patents given to Gilead Sciences for the drug remdesivir so it can be distributed more fairly to coronavirus..
Reuters India - Published

Japan says drugmaker Gilead's COVID-19 treatment remdesivir now in use in hospitals

Japan has begun treating severely ill COVID-19 patients with Gilead Sciences Inc's COVID-19 remdesivir drug, a health ministry official said, just days after giving the drug emergency approval as it..
Reuters India - Published

Gilead signs pact with generic drugmakers in India to expand supply of experimental COVID-19 drug remdesivir

Globally, the virus has infected a total of 4.23 million people as of now while the number of deaths has reached 290000.
DNA - Published

Gilead ties up with generic drugmakers for COVID-19 drug supply

Gilead Sciences Inc said on Tuesday it has signed non-exclusive licensing pacts with five generic drugmakers based in India and Pakistan to expand the supply of its experimental COVID-19 treatment..
Reuters India - Published

India's Jubilant signs licensing deal for Gilead's COVID-19 drug

India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries,..
Reuters India - Published

Japan approves Gilead Sciences' remdesivir as COVID-19 drug

Japan has approved Gilead Sciences Inc's remdesivir as a treatment for COVID-19, the health ministry said on Thursday, making it the country's first officially authorised drug for the disease.
Reuters - Published

Will Gilead price its coronavirus drug for public good or company profit?

Gilead Sciences Inc faces a new dilemma in deciding how much it should profit from the only treatment so far proven to help patients infected with the novel coronavirus.
Reuters India - Published

Gilead in talks to expand global supply of COVID-19 drug remdesivir

Gilead Sciences Inc said on Tuesday it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug remdesivir for Europe, Asia and the developing world through at..
Reuters India - Published

Japan aims to fast-track review of anti-viral drug remdesivir

Japan will fast-track a review of Gilead Sciences Inc's antiviral drug remdesivir so that it can hopefully be approved for domestic COVID-19 patients a week after the U.S. firm's filing for such..
Reuters - Published

Gilead starts two late-stage studies to test drug for coronavirus

Gilead Sciences Inc said on Wednesday it has started two late-stage studies to test its drug in patients with coronavirus.
Reuters - Published

U.S. begins first coronavirus clinical trial testing Gilead's experimental drug

U.S. health officials said on Tuesday the first clinical trial testing Gilead Sciences Inc's experimental antiviral drug, remdesivir, in hospitalized patients with the coronavirus has started.
Reuters - Published

Gilead drug prevents type of coronavirus in monkeys; raises hope for China trials

An experimental Gilead Sciences antiviral drug prevented disease and reduced the severity of symptoms in monkeys infected with Middle East Respiratory Syndrome (MERS), an infection closely related to..
Reuters - Published

China lab seeks patent on use of Gilead's coronavirus treatment

A state-run Chinese research institute has applied for a patent on the use of Gilead Sciences' experimental U.S. antiviral drug, which scientists think could provide treatment for the coronavirus that..
Reuters - Published

Gilead working with China to test Ebola drug as new coronavirus treatment

Gilead Sciences Inc said on Friday it provided its experimental Ebola therapy for use in a small number of patients with the Wuhan coronavirus and is working with China's health authorities to set up a..
Reuters - Published

Gilead assessing potential use of Ebola drug as China virus treatment

Gilead Sciences Inc said on Thursday it was assessing whether its experimental Ebola treatment could be used to treat the new coronavirus that has caused a disease outbreak in China.
Reuters - Published